BSE filing, NSE: NEELKATEC. Summary written from the filing by ALFA Finder's alert engine.
Zenlabs Ethica Ltd: key numbers
- Share price
- ₹25.50
- Market cap
- ₹16.60 Cr
- Revenue (annual)
- ₹46.92 Cr
- Net profit (annual)
- ₹-1.94 Cr
- P/E (TTM)
- -6.5×Sector 47.2×
- Promoter holding
- 52.96%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenlabs Ethica Ltd
All →Zenlabs Ethica Board Meeting Date
Zenlabs Ethica will hold a board meeting on 12 November 2026 to consider unaudited quarterly results for September 2026. Agenda items are proposed only.
Zenlabs Ethica Other Announcement
Zenlabs Ethica Ltd submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Zenlabs Ethica Management Change
Zenlabs Ethica Ltd. announced the resignation of Mr. Nikunj Goel as Company Secretary and Compliance Officer, effective October 05, 2026.
Zenlabs Ethica Other Announcement
Zenlabs Ethica Ltd announced the re-appointment of M/s. N. Kumar Chabbra & Co. as Statutory Auditors for a five-year term, approved at the 33rd AGM.
- Execution
- 5 years
Zenlabs Ethica Annual General Meeting
Zenlabs Ethica Ltd conducted its 33rd Annual General Meeting on September 29, 2026. Shareholders considered resolutions for adopting financial statements, auditor reappointment, and amending the memorandum of association.
Zenlabs Ethica Annual Report
Zenlabs Ethica Ltd has submitted its 33rd Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 29, 2026.
Other business update announcements
All →Italian Edibles Business Update
Italian Edibles revised its project timeline again, pushing commercial production from January 2027 to April 2027. Construction delays stem from steel prices, supply chain disruption, weather and labour shortages.
- Execution
- Commercial production revised to April 2027 from January 2027
Bajaj Finserv Business Update
Bajaj Finserv disclosed October 2026 monthly premium and new business data for its unlisted insurance subsidiaries. The figures are provisional.
Bajaj Finance Business Update
Bajaj Finance submitted its Half Yearly Report for FY2026-27 covering the six months to 30 September 2026. The report shows 28% consolidated PAT growth to ₹12,447 crore and a planned ₹17,500 crore capital raise.
Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years